Cardiovascular Effects of Very Low Nicotine Content Cigarettes
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jan 31, 2023
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how very low nicotine content cigarettes affect the heart and blood vessels in both daily and non-daily smokers. Researchers want to understand if smoking these types of cigarettes has different cardiovascular effects compared to regular cigarettes. The study is currently looking for participants aged 21 and older who have smoked at least once in the last month and are willing to smoke either the research cigarettes or their usual brand during a lab visit.
If you decide to join, you'll need to meet certain health criteria. For example, you cannot have a recent diagnosis of heart or blood vessel diseases, and you should not be pregnant or breastfeeding. During the study, you'll be asked to smoke in a controlled setting, and the researchers will monitor your heart health and other measurements. This trial aims to gather important information that could help improve smoking cessation efforts and understand the impacts of different types of cigarettes on cardiovascular health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-reported cigarette smoking at least once in the past 30 days
- • ≥21 years old
- • Willingness to smoke research cigarettes or usual brand cigarettes during lab visit.
- • Ability to speak, comprehend, and read English sufficiently to complete study procedures
- Exclusion Criteria:
- • Self-reported diagnosis of cardiovascular diseases like coronary artery disease, stroke, peripheral artery disease, cardiac arrhythmia, pulmonary embolism \& blood clots in legs and arm in the past 3 months
- • Body temperature ≥ 100.4˙F
- • Unstable health conditions interfering with electrocardiogram (ECG) measurements
- • Self-reported diagnosis of hyperthyroidism or thyrotoxicosis
- • Currently pregnant (as indicated by urine pregnancy test at the start of laboratory visit) or breastfeeding.
- • Currently seeking treatment to quit smoking
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Eric C Donny, PhD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials